Clinical Trial Update: Oxaliplatin and Capecitabine in Patients With Unresectable Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin and capecitabine in patients with unresectable cholangiocarcinoma; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma
• Gallbladder Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Cancer of the Gallbladder, Cancer of the Biliary Tract | Phase 2 | Status: COMPLETED | Results posted: 2010-12-08